ArticleCirculation reports2025
Validation for the Diagnostic Use of the HEART Score in Patients With Acute Chest Pain in Japan.
Article in Circulation reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Characteristics and In-Hospital Outcomes of Self-Transport Patients With Acute Myocardial Infarction: A Nationwide Analysis.Circulation reports · 2026Article
- Evaluating the Efficacy of CPS, HEART and TIMI Score in Emergency Department Patients with Non-Traumatic Chest Pain: A Pilot Study.Medical sciences (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Current clinical guidelines recommend that patients with acute chest pain and suspected acute coronary syndrome (ACS) should be assessed using a risk scoring system. The History, Electrocardiogram, Age, Risk factors and Troponin (HEART) score is one such scoring system; however, large-scale validation studies remain limited in Japan. Methods and Results: This study analyzed 487 patients presenting with chest pain in our emergency department (ED) between April and December 2022. We enrolled patients with suspected ACS without ST-segment elevation and shock state. The primary outcome was major adverse cardiovascular events (MACE) within 30 days following the ED visit. The endpoint occurred in 108 patients, including 90 patients with myocardial infarction. The HEART score identified 140 (28%) low-risk patients with a HEART score ≤3 who did not have any endpoint occurrence within 30 days. The area under the curve (AUC) values of the HEART score for MACE was 0.87. The results were more favorable when the highest troponin level was considered in calculating the conventional HEART score. Conclusions: The HEART score was reliable for predicting MACE within 30 days in patients presenting to the ED with chest pain in this single center study in Japan. Low-risk patients with HEART scores ≤3 can be safely ruled out for ACS. Considering the highest troponin level for scoring improved its diagnostic utility.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.